Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

AlphaTON Capital Corp.

Financial Services US ATON

0.2895USD
-0.2035(41.28%)

Last update at 2026-06-08T13:30:00Z

Day Range

0.260.29
LowHigh

52 Week Range

0.2213.80
LowHigh

Fundamentals

  • Previous Close 0.49
  • Market Cap7.50M
  • Volume9401967
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.08650M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-8.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -6.78100M -85.69700M -122.52200M -14.81700M -14.89200M
Minority interest 0.01M 0.04M 0.06M 2.30M -
Net income -6.76700M -75.33900M -104.61100M -16.87000M -15.83300M
Selling general administrative 4.25M 5.66M 8.36M 8.82M 5.13M
Selling and marketing expenses - - - - -
Gross profit -0.03500M -0.05400M -0.00100M - -
Reconciled depreciation 0.04M 0.05M 0.00100M 0.00000M -
Ebit -6.77800M -18.25300M -122.25300M -30.30000M -26.42600M
Ebitda -6.74300M -18.19900M -122.25200M -14.77400M -14.71500M
Depreciation and amortization 0.04M 0.05M 0.00100M 15.59M 12.24M
Non operating income net other - - - - -
Operating income -7.41800M -18.25300M -16.57600M -15.58800M -12.44000M
Other operating expenses 7.42M 18.25M 16.58M 15.59M 12.44M
Interest expense 0.00300M 0.03M 0.00900M 0.04M 0.18M
Tax provision -0.00300M -10.54800M -17.85600M 4.35M -
Interest income 0.09M 0.27M 0.22M 0.00000M -
Net interest income 0.09M 0.24M 0.21M -0.04300M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.00300M -10.54800M -17.85600M 4.35M 2.30M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M -
Total operating expenses 7.38M 18.20M 16.57M 15.59M 12.44M
Cost of revenue 0.04M 0.05M 0.00100M - -
Total other income expense net 0.64M -67.44400M -105.94600M 0.77M -2.45200M
Discontinued operations - - - - -
Net income from continuing ops -6.77800M -75.38200M -104.66600M -19.16900M -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 2.23M 7.78M 99.13M 194.66M 174.86M
Intangible assets - - 81.68M 117.39M 117.39M
Earning assets - - - - -
Other current assets 0.54M 2.63M 2.45M 1.27M 1.49M
Total liab 3.05M 4.45M 23.73M 29.23M 27.26M
Total stockholder equity -0.12300M 4.02M 76.05M 121.20M 101.45M
Deferred long term liab - - - - -
Other current liab 0.67M 2.36M 1.59M 0.59M 2.94M
Common stock 221.80M 219.50M 218.78M 158.32M 130.65M
Capital stock 221.80M 219.50M 218.78M 158.32M -
Retained earnings -245.45300M -239.31800M -159.61600M -55.00500M -38.13500M
Other liab - - - - -
Good will - - 0.00000M 43.32M 43.32M
Other assets - - - - -
Cash 1.67M 5.03M 10.54M 23.35M 2.77M
Cash and equivalents - - - - -
Total current liabilities 1.10M 2.88M 1.86M 0.78M 3.21M
Current deferred revenue - - - - -
Net debt -1.67000M -4.98100M -10.54500M -23.35200M -2.62000M
Short term debt - 0.04M - - 0.15M
Short long term debt - - - - -
Short long term debt total - 0.05M - - 0.15M
Other stockholder equity - - - 16.93M 7.98M
Property plant equipment - - - - -
Total current assets 2.23M 7.70M 13.68M 24.83M 4.95M
Long term investments - 0.00000M 2.89M 9.08M -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.01M 0.04M 0.68M 0.21M 0.68M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.43M 0.48M 0.27M 0.19M 0.11M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 23.53M 23.84M 16.88M 0.96M 0.96M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.05M 0.88M 0.04M 0.06M
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.08M 85.45M 169.83M 169.91M
Capital lease obligations 0.00000M 0.05M 0.00000M - -
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 0.00000M 2.81M -0.61700M 0.00000M -
Change to liabilities - - - - -
Total cashflows from investing activities - 2.81M -0.61700M - -0.86000M
Net borrowings -0.04700M -0.04000M -2.00000M 0.00000M -
Total cash from financing activities 2.10M 5.97M -0.11700M 27.35M 4.76M
Change to operating activities - - - - -
Net income -6.77800M -75.33900M -104.66600M -19.16900M -17.18900M
Change in cash -3.35800M -5.51700M -12.80700M 20.58M -0.38200M
Begin period cash flow 5.03M 10.54M 23.35M 2.77M 3.15M
End period cash flow 1.67M 5.03M 10.54M 23.35M 2.77M
Total cash from operating activities -5.46200M -14.29700M -12.07300M -6.76400M -4.28400M
Issuance of capital stock 2.15M 6.03M 2.98M 29.09M -
Depreciation 0.04M 0.05M 0.00100M 0.00000M 1.02M
Other cashflows from investing activities - - -0.61400M - -0.00086M
Dividends paid - - - - -
Change to inventory - - - 1.21M -0.88000M
Change to account receivables 1.57M -0.03200M -0.03100M 0.52M -0.11100M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.00100M -0.02000M -1.09900M -1.74700M -1.24800M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00300M 0.00000M 1.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.52M 0.98M -0.01000M -0.46100M -0.74400M
Stock based compensation 0.32M 0.00264M 4.28M 9.14M 8.83M
Other non cash items -0.55800M 70.57M 106.21M -0.67000M 1.36M
Free cash flow -5.46200M -14.29700M -12.07600M -6.76400M -3.28314M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ATON
AlphaTON Capital Corp.		 -0.2035 41.28% 0.29 - - 216.00 0.80 431.99 0.77
BLK
BlackRock Inc		 11.68 1.17% 1006.45 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc		 5.46 4.79% 119.66 33.20 20.12 11.05 11.56 9.14 15.74
BN
Brookfield Corp		 1.07 2.42% 45.30 94.78 11.89 1.35 2.37 4.58 10.79
IVSXF
Investor AB (publ)		 -0.36 0.89% 40.05 20.83 - 0.88 1.11 10.01 1.68

Reports Covered

Stock Research & News

View All

Profile

AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

Clarence Thomas Building, Road Town, British Virgin Islands, VG1110

Key Executives

Name Title Year Born
Dr. Robert A. Kramer Ph.D. Chief Scientific Officer 1952
Mr. Fiorenzo A. Villani Executive Chairman & Chief Investment Officer 1971
Ms. Brittany Kaiser CEO & Director 1989
Mr. Wesley Allen Levitt C.F.A. Chief Financial Officer 1988
Mr. Logan Ryan Golema Chief Technology Officer NA
Mr. William De'Ath Chief Partnership Officer NA
Adam Melero Controller NA
Mr. Peter Molloy Chief Executive Officer of Cyncado Therapeutics Inc. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.